MCCN — Medcolcanna Organics Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Medcolcanna Organics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 0 | 0.002 | 0.096 |
| Cost of Revenue | |||
| Gross Profit | — | 0.001 | 0.022 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | — | 7.22 | 7.53 |
| Operating Profit | 0 | -7.21 | -7.43 |
| Net Income Before Taxes | — | -7.21 | -7.43 |
| Provision for Income Taxes | |||
| Net Income After Taxes | — | -7.21 | -7.36 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | — | -7.21 | -7.27 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Dilution Adjustment | |||
| Diluted Net Income | 0 | -7.21 | -7.27 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | — | -0.067 | -0.068 |